Retour sur lavenir.net
   UCB 231.200 € (+2,21 %)     MELEXIS 71.350 € (+5,70 %)     AEDIFICA 71.850 € (+0,98 %)     KBC 113.250 € (-0,09 %)     ARGENX SE 668.000 € (+1,83 %)     AGEAS 66.700 € (+0,23 %)     EVS BROADC.EQUIPM. 37.500 € (+1,63 %)     AB INBEV 64.400 € (+2,88 %)     AZELIS GROUP 11.280 € (+1,90 %)     GIMV 48.000 € (+0,42 %)     ONTEX GROUP 2.910 € (+0,17 %)     BARCO 9.525 € (+0,90 %)     CARE PROPERTY INV. 12.940 € (+0,94 %)     PROXIMUS 6.510 € (+0,46 %)     CFE 11.350 € (+1,79 %)     SIPEF 101.600 € (+2,32 %)     RETAIL ESTATES 67.900 € (+1,04 %)     DEME GROUP 194.000 € (+3,85 %)     BREDERODE 103.000 € (+0,59 %)     ONWARD MEDICAL 2.660 € (+0,38 %)     TITAN S.A. 46.120 € (+0,48 %)     CAMPINE 220.000 € (+2,33 %)     BEKAERT 41.950 € (+0,84 %)     NEXTENSA 46.945 € (+0,42 %)     HOME INVEST BE. 19.200 € (-0,52 %)     RECTICEL 10.100 € (+1,61 %)     NYXOAH 2.530 € (+1,20 %)     BIOTALYS 3.000 € (+1,87 %)     TINC 12.020 € (+0,67 %)     ELIA GROUP 141.400 € (+2,39 %)     JENSEN-GROUP 68.600 € (-0,58 %)     SHURGARD 26.200 € (+1,16 %)     ASCENCIO 49.850 € (+0,71 %)     SYENSQO 56.350 € (+1,53 %)     SOFINA 218.000 € (+1,02 %)     BANQUP GROUP 2.450 € (-2,00 %)     COLRUYT 32.840 € (-0,48 %)     VIOHALCO 14.600 € (-2,01 %)     FAGRON 24.000 € (0,00 %)     ORANGE BELGIUM 21.000 € (0,00 %)     FLUXYS BELGIUM D 21.800 € (0,00 %)     XIOR 27.600 € (+0,91 %)     IBA 13.380 € (-0,45 %)     EXMAR 10.800 € (+1,89 %)     VAN DE VELDE 32.700 € (+0,31 %)     ECONOCOM GROUP 1.415 € (-2,41 %)     KINEPOLIS GROUP 30.600 € (-0,16 %)     TUBIZE-FIN 195.700 € (+2,19 %)     CMB.TECH 11.620 € (+2,11 %)     CIE BOIS SAUVAGE 334.000 € (+3,09 %)     DECEUNINCK 2.140 € (-0,70 %)     ACKERMANS V.HAAREN 280.200 € (+1,74 %)     KBC ANCORA 77.700 € (0,00 %)     BPOST 1.810 € (+1,46 %)     LOTUS BAKERIES 10 260.000 € (+1,18 %)     VGP 87.300 € (+0,23 %)     D'IETEREN GROUP 175.600 € (+0,46 %)     SOLVAC NOM(RETAIL) 75.000 € (-0,66 %)     GBL 79.500 € (+0,82 %)     IMMOBEL 22.100 € (+5,74 %)  
   CAPGEMINI 103.000 € (+0,29 %)     HYDROGEN REFUELING 1.470 € (-6,73 %)     PHILIPS KON 22.390 € (+2,14 %)     KLARSEN 0.548 € (+83,89 %)     BOIRON 27.400 € (+4,58 %)     PROLOGUE 0.254 € (+0,79 %)     STMICROELECTRONICS 46.015 € (+2,90 %)     KERING 232.650 € (+0,04 %)     TETRAGON FIN GRP 13.300 € (-2,21 %)     SOITEC 126.950 € (+12,25 %)     VEOLIA ENVIRON. 35.940 € (+3,25 %)     MAGNUM 12.440 € (+11,45 %)     PAULIC MEUNERIE 1.580 € (+11,27 %)     ING GROEP N.V. 24.755 € (+3,66 %)     POSTNL 0.948 € (+0,69 %)     GASCOGNE 2.360 € (+9,26 %)     VALLOUREC 25.650 € (+2,35 %)     CIECHARGEURSINVEST 8.440 € (-2,54 %)     AIRBUS 174.880 € (+0,15 %)     ASML HOLDING 1 222.400 € (+2,50 %)     PROSUS 41.070 € (+1,03 %)     LVMH 451.400 € (+0,66 %)     SHELL PLC 38.510 € (+1,80 %)     VINCI 128.500 € (+1,86 %)     IMCD 100.150 € (+3,01 %)     CVC CAPITAL 12.950 € (+3,52 %)     TECHNIP ENERGIES 40.300 € (-0,05 %)     FDJ UNITED 23.100 € (-1,53 %)     E PANGO 0.190 € (-23,08 %)     ALSTOM 17.080 € (+4,27 %)     AMUNDI 82.200 € (+1,29 %)     ASR NEDERLAND 64.560 € (+0,91 %)     TOTALENERGIES 79.290 € (+1,35 %)     SARTORIUS STED BIO 156.700 € (+3,43 %)     EXOR NV 66.800 € (+0,91 %)     CARMILA 16.980 € (-0,12 %)     BE SEMICONDUCTOR 247.200 € (+3,26 %)     DANONE 66.740 € (+0,97 %)     BUREAU VERITAS 26.060 € (+0,81 %)     EXAIL TECHNOLOGIES 123.600 € (-0,24 %)     HEINEKEN HOLDING 60.400 € (+1,85 %)     ARKEMA 62.000 € (+1,06 %)     ASM INTERNATIONAL 830.600 € (+2,57 %)     IPSEN 167.000 € (+2,52 %)     COVIVIO 56.200 € (+0,54 %)     SANOFI 79.820 € (+1,92 %)     NEXANS 158.100 € (+3,27 %)     SAINT GOBAIN 77.640 € (+1,54 %)     SOCIETE GENERALE 68.440 € (-3,59 %)     AHOLD DEL 40.020 € (+0,58 %)     LEGRAND 151.800 € (+1,57 %)     FUGRO 12.350 € (+7,11 %)     GECINA 71.850 € (+0,42 %)     FRANCAISE ENERGIE 38.000 € (-0,91 %)     STELLANTIS NV 6.215 € (-6,40 %)     KAUFMAN ET BROAD 27.650 € (+0,55 %)     NN GROUP 74.300 € (+0,92 %)     ISPD 1.740 € (0,00 %)     EKINOPS 2.490 € (-2,92 %)     MYHOTELMATCH 0.174 € (-1,14 %)  
WATERA
ALWTR - FR001400IUV6 - Euronext Paris
1,170 €  17:35
-2,50 %
30/04/2026 18:30

FY 2025 results

  • Significant improvement in operating earnings during the second half, thanks to cost streamlining, improved operational efficiency and the completion of major projects 
  • Financial structure strengthened by new equity investment from Unibios 
  • Further improvement in performance expected in 2026

 

Chartres, 30 April 2026 – WATERA, a leading provider of solar-powered seawater and brackish water desalination solutions, today announces its results for the year ended 31 December 2025[1].

Orfeas Mavrikios, Chairman and CEO of WATERA, said: “The merger of OSMOSUN (now WATERA) with Watera International marks a pivotal milestone for the Company. Henceforth we will be gradually aligning our organisational system and methods with those of our parent company, Unibios, with the aim of raising our standards of execution and operational discipline.

The measures taken in recent months are beginning to bear fruit, leading to a noticeable improvement in results during the second half: the announced cost-saving plan has been implemented, teams have been reorganised and work processes standardised. Against this backdrop, signs of a recovery were already appearing towards the end of 2025.

We therefore enter 2026 with a more streamlined cost structure which, coupled with the gradual recovery in business, should enable us to continue improving profitability.”

 

Highlights of the 2025 financial year

As a reminder, in July 2025 OSMOSUN (now WATERA) joined forces with Watera International, a Luxembourg-based subsidiary of Unibios and a recognised player in water treatment in Greece since 1963, operating through its subsidiary Watera Hellas, a national leader in installed desalination capacity. Outside the Greek market, Watera International has developed a strong presence through subsidiaries in the Czech Republic, Bulgaria and Italy, while running a significant export business covering Western and Eastern Europe, the Middle East and Africa.

As part of this merger, WATERA carried out two cash capital increases totalling €2.0 million (€1.6 million from Unibios and €0.4 million from existing shareholders) and a capital increase reserved for Unibios in exchange for the contribution of a 30% stake in its subsidiary Watera International, valued at €6.6 million.

Following these transactions, Unibios holds a 65% stake in WATERA.

 

Income statement analysis

 €000H1 2024H2 20242024H1 2025H2 20252025
Revenues[2]1,5053691,8746161,1931,809
EBITDA[3](2,495)(2,781)(5,276)(1,246)(760)(2,006)
Operating income(2,728)(3,418)(6,145)(1,401)(913)(2,315)
Net income(2,633)(3,695)(6,328)(1,460)(708)(2,168)

2025 revenues amounted to €1.8 million (versus €1.9 million in 2024), driven by large-scale contracts signed in 2022 and 2023, particularly in the Caribbean and Africa. Revenues also include the contribution from completed tourism sector projects in the Pacific, as well as new contracts signed in 2025, notably in France, Africa and the Caribbean.

The EBITDA loss was €2.0 million, compared to a €5.3 million loss in 2024. This improvement is mainly due to:

  • a reduction in procurement costs following the completion of major contracts. Furthermore, since the merger with Unibios in July 2025, the Company has benefited from more favourable procurement terms and a more rigorous purchasing policy;
  • less reliance on subcontracting, also linked to the completion of major contracts, whereas 2024 had been impacted by cost overruns on these same projects;
  • the initial effects of the operating cost reduction plan, which generated savings of €0.5 million, driven mainly by the reduction in the wage bill following staff cuts (24 FTE[4] in 2025 compared to 32 FTE in 2024) and the work expended on streamlining costs, particularly in relation to rental payments, transport, business travel and fees.

After depreciation, amortisation and provisions totalling €0.3 million, operating loss came to €2.3 million (compared to a €6.1 million loss in 2024).

The net loss amounted to €2.2 million (compared to a €6.3 million loss in 2024), including €0.2 million in dividends paid by Watera International, in which WATERA holds a 30% stake.

 

Financial structure analysis

At 31 December 2025, equity stood at €7.6 million, compared to €1.2 million at 31 December 2024, boosted by the proceeds from the capital increases carried out in the summer of 2025.

Following the €0.7 million loan repayment made during the second half, cash and cash equivalents stood at €1.0 million versus gross borrowings of €1.0 million, including €0.6 million due within one year.

To ensure business continuity, Unibios has committed to taking the required steps to provide financial support to the Company over a 12-month period. Accordingly, WATERA received a €1.0 million loan from Watera International in February 2026.

 

Strengthened governance

Since the merger with Unibios, the Company has taken several significant steps marking a new phase in its development and governance.

On 30 September 2025, Orfeas Mavrikios, already Chairman of the Board of Directors and CEO of Watera International, as well as CEO of Unibios, was appointed Chairman of the Board of Directors and CEO of the Company. This appointment has helped strengthen the Company's strategic alignment within the new group.

In March 2026, governance was strengthened with the appointment of two independent directors, Vasiliki Niatsou and Vassilis Pavlopoulos, who bring further legal expertise to the Board of Directors. At the same time, Maxime Therrillion, recently appointed Deputy CEO of the Company and an employee at WATERA since 2016, joined the Board of Directors.

Finally, this transformation coincided with a significant symbolic step: following a decision by the General Meeting on 11 March 2026, the Company adopted the corporate name of “WATERA”, replacing OSMOSUN, thereby establishing a new identity consistent with the strategic merger.

 

Outlook

Contracts signed to date represent €1.1 million in revenue to be recognised mainly in 2026.

Meanwhile, following the merger with Unibios in July 2025, the second half of 2025 already posted a significant reduction in the loss. This improvement is the result of several converging factors: the initial tangible effects of cost streamlining measures; the gradual integration of Unibios Group organisational methods and operational policies, enabling improved operational efficiency and procurement terms; and the refocusing of the business on more standardised, higher-margin machinery following the completion of major projects signed in 2022 and 2023.

The savings generated by the reorganization plan implemented in the second half of 2025 will have their full impact in 2026, with a cost reduction of €1.2 million compared to the 2024 cost structure, mainly driven by lower personnel expenses and reduced external spending.

Against this backdrop, WATERA enters the 2026 financial year with confidence. The renewed momentum observed at the end of 2025, supported by reorganised teams now aligned with optimised working methods, provides a solid foundation for continued performance improvement. Bolstered by the synergies arising from the merger with Unibios, a sustainably streamlined cost structure and a refocused positioning on higher value-added offerings, WATERA is on track towards a gradual improvement in profitability.

The annual accounts are available in the appendices of the pdf document.

 

Next publication: First-half 2026 results, September 30, 2026

 

ABOUT WATERA

Founded in 2014, WATERA (previously OSMOSUN) operates in the “low-carbon” water market and stands out thanks to a unique, patented, cost-effective, clean and sustainable solution for solar-powered battery-free seawater and brackish water desalination.

In July 2025, Unibios, a Greek company listed on the Athens Stock Exchange, became WATERA's majority shareholder, thereby strengthening and expanding the Group's position in the sustainable water treatment and wastewater reuse sectors through its 30% stake in Watera International, Unibios' main subsidiary.

WATERA is aiming to become a key international player in water treatment by providing sustainable and competitive technological systems capable of meeting the global challenges of responsible water management and access to drinking water.

 

CONTACTS

SPECIALIST PRESSFINANCIAL PRESSINVESTOR RELATIONS
Nadège ChapelinDéborah SchwartzHélène de Watteville
n.chapelin@nc-2.comdschwartz@actus.frwatera@actus.fr
+33 6 52 50 33 58+33 1 53 67 36 35+33 1 53 67 36 33

 


[1]The annual financial statements were approved by the Board of Directors on 29 April 2026. The financial statements have been certified without reservation by the Statutory Auditors, with an observation drawing attention to Note 9.3.4. “Going Concern,” in the notes to the annual financial statements, relating to the support received from the parent company. The annual financial report will be published today.

[2] The company applies the percentage-of-completion method to recognize revenue on turnkey projects specifically negotiated under a contract. Revenue from the sale of standardized equipment and spare parts is recognized upon transfer of ownership.

[3] EBITDA is a measure of operating performance, defined as operating income adjusted for net depreciation, amortization, and provisions.

[4] Full-time equivalent



Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière